AI Terminal
Target Healthcare REIT PLC
Board/Management Information • Mar 5, 2025
5028_rns_2025-03-05_e44e4949-6a6d-45de-baff-b353b0948397.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 3455Z
Target Healthcare REIT PLC
05 March 2025
5 March 2025
Target Healthcare REIT plc and its subsidiaries
("Target Healthcare" or "the Group")
Appointment of Joint Broker
Target Healthcare (LSE: THRL), the UK listed specialist investor in modern, purpose-built care homes, is pleased to announce the appointment of Panmure Liberum Limited ("Panmure Liberum") as joint broker, to work alongside Stifel Nicolaus Europe Limited, the Group's existing corporate broker, with immediate effect.
LEI: 213800RXPY9WULUSBC04
For further information, please contact:
| Target Fund Managers Limited | Tel: 01786 845 912 |
| Kenneth MacKenzie Gordon Bland |
|
| Stifel Nicolaus Europe Limited | Tel: 020 7710 7600 |
| Mark Young Rajpal Padam Catriona Neville |
|
| Panmure Liberum Limited | Tel: 020 3100 2000 |
| Jamie Richards David Watkins Nikhil Varghese Dougie McLeod |
|
| FTI Consulting | Tel: 020 3727 1000 |
| Dido Laurimore Richard Gotla |
[email protected] |
Notes to editors:
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.
The Group's portfolio at 31 December 2024 comprised 94 assets let to 34 tenants with a total value of £924.7 million.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPDZLFBEXLFBBD